Structure guided prediction of Pyrazinamide resistance mutations in pncA
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure guided prediction of Pyrazinamide resistance mutations in pncA
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-05
DOI
10.1038/s41598-020-58635-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania
- (2019) Saumu Pazia Juma et al. BMC INFECTIOUS DISEASES
- Empirical ways to identify novel Bedaquiline resistance mutations in AtpE
- (2019) Malancha Karmakar et al. PLoS One
- Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy
- (2018) Malancha Karmakar et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- NGL viewer: web-based molecular graphics for large complexes
- (2018) Alexander S Rose et al. BIOINFORMATICS
- Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam
- (2018) Kathryn E. Holt et al. NATURE GENETICS
- DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability
- (2018) Carlos HM Rodrigues et al. NUCLEIC ACIDS RESEARCH
- Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis
- (2018) Stephanie Portelli et al. Scientific Reports
- A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
- (2017) Paolo Miotto et al. EUROPEAN RESPIRATORY JOURNAL
- Combating mutations in genetic disease and drug resistance: understanding molecular mechanisms to guide drug design
- (2017) Amanda T.S. Albanaz et al. Expert Opinion on Drug Discovery
- Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures
- (2017) Harry C Jubb et al. JOURNAL OF MOLECULAR BIOLOGY
- A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
- (2017) Adam N. Yadon et al. Nature Communications
- Genetic Determinants of Drug Resistance inMycobacterium tuberculosisand Their Diagnostic Value
- (2016) Maha R. Farhat et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Missense mutations in the unfoldase ClpC1 of the caseinolytic protease complex are associated with pyrazinamide resistance in Mycobacterium tuberculosis
- (2016) Michelle Yee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance
- (2016) Jody Phelan et al. BMC Medicine
- CSM-lig: a web server for assessing and comparing protein–small molecule affinities
- (2016) Douglas E.V. Pires et al. NUCLEIC ACIDS RESEARCH
- Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses
- (2016) Ana Carolina Rios Silvino et al. PLoS One
- mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance
- (2016) Douglas E. V. Pires et al. Scientific Reports
- The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants
- (2016) Flora S. Kano et al. PLoS Neglected Tropical Diseases
- The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis
- (2016) Vinayak Singh et al. ACS Infectious Diseases
- Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis
- (2016) Yumi Park et al. ACS Infectious Diseases
- In silico functional dissection of saturation mutagenesis: Interpreting the relationship between phenotypes and changes in protein stability, interactions and activity
- (2016) Douglas E. V. Pires et al. Scientific Reports
- Better prediction of functional effects for sequence variants
- (2015) Maximilian Hecht et al. BMC GENOMICS
- Mycobacterium tuberculosispncAPolymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT: TABLE 1
- (2015) Michael G. Whitfield et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mycobacterial DNA Extraction for Whole-Genome Sequencing from Early Positive Liquid (MGIT) Cultures
- (2015) Antonina A. Votintseva et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
- (2015) Rodney Dawson et al. LANCET
- Genome-wide Mycobacterium tuberculosis variation (GMTV) database: a new tool for integrating sequence variations and epidemiology
- (2014) Ekaterina N Chernyaeva et al. BMC GENOMICS
- DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach
- (2014) D. E. V. Pires et al. NUCLEIC ACIDS RESEARCH
- Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
- (2014) P. Miotto et al. mBio
- Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA
- (2014) David B. Ascher et al. Scientific Reports
- Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
- (2014) Wanliang Shi et al. Emerging Microbes & Infections
- mCSM: predicting the effects of mutations in proteins using graph-based signatures
- (2013) Douglas E. V. Pires et al. BIOINFORMATICS
- Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience
- (2013) S. Hoffner et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Systematic Analysis of Pyrazinamide-Resistant Spontaneous Mutants and Clinical Isolates of Mycobacterium tuberculosis
- (2012) Karolien Stoffels et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predicting the Functional Effect of Amino Acid Substitutions and Indels
- (2012) Yongwook Choi et al. PLoS One
- Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology
- (2012) Claudio U. Köser et al. PLoS Pathogens
- Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses
- (2011) Kwok Chiu Chang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Validation of pncA Gene Sequencing in Combination with the Mycobacterial Growth Indicator Tube Method To Test Susceptibility of Mycobacterium tuberculosis to Pyrazinamide
- (2011) S. O. Simons et al. JOURNAL OF CLINICAL MICROBIOLOGY
- SDM--a server for predicting effects of mutations on protein stability and malfunction
- (2011) C. L. Worth et al. NUCLEIC ACIDS RESEARCH
- Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide
- (2011) Stéphanie Petrella et al. PLoS One
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
- (2011) W. Shi et al. SCIENCE
- Potential for Erroneous Results Indicating Resistance When Using the Bactec MGIT 960 System for Testing Susceptibility ofMycobacterium tuberculosisto Pyrazinamide
- (2009) Pamela Chedore et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand
- (2009) Sushil Pandey et al. PATHOLOGY
- Tuberculosis Drug Resistance Mutation Database
- (2009) Andreas Sandgren et al. PLOS MEDICINE
- A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis
- (2008) Nicolas Veziris et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now